Hutchin Hill Capital’s Bristol-Myers Squibb BMY Stock Holding History

Hutchin Hill Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-28,522	Closed	-$1.56M	–	892
2016 Q4	$1.67M	Buy	+28,522	New	+$1.56M	0.06%	358
2016 Q2	–	Sell	-26,000	Closed	-$1.66M	–	537
2016 Q1	$1.66M	Buy	26,000 +2,600	+11%	+$164K	0.05%	326
2015 Q4	$1.61M	Buy	+23,400	New	+$1.55M	0.04%	341
2015 Q2	–	Sell	-7,600	Closed	-$490K	–	661
2015 Q1	$490K	Sell	7,600 -2,000	-21%	-$125K	0.01%	550
2014 Q4	$567K	Sell	9,600 -20,000	-68%	-$1.13M	0.02%	428
2014 Q3	$1.51M	Buy	29,600 +4,800	+19%	+$240K	0.06%	300
2014 Q2	$1.2M	Buy	24,800 +18,100	+270%	+$892K	0.05%	312
2014 Q1	$348K	Buy	+6,700	New	+$357K	0.02%	511
2013 Q3	–	Sell	-55,500	Closed	-$2.48M	–	484
2013 Q2	$2.48M	Buy	+55,500	New	+$2.41M	0.26%	66

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hutchin Hill Capital's BMY Position: Q1 2017 in Review

Hutchin Hill Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 28,522 shares — an estimated $1.56M sold.

Hutchin Hill Capital first reported a position in BMY in Q2 2013 and held it in 9 quarters. The position peaked at $2.48M in Q2 2013. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

Hutchin Hill Capital reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
Hutchin Hill Capital sold 28,522 Bristol-Myers Squibb shares in Q1 2017, an estimated $1.56M.
Hutchin Hill Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 9 quarters.
Hutchin Hill Capital's Bristol-Myers Squibb position peaked at $2.48M in Q2 2013.
1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Hutchin Hill Capital's 13F filing for Q1 2017, filed 15 May 2017.